Warning Letter — AHC Products, Inc.
The FDA issued a Warning Letter to AHC Products, Inc. following a review by the Center for Veterinary Medicine.
AHC Products, Inc. and manufacturers of veterinary products subject to Center for Veterinary Medicine oversight.
This enforcement action indicates that the FDA is actively monitoring veterinary product compliance. While the provided excerpt does not detail the specific violations, the issuance of a Warning Letter by the Center for Veterinary Medicine typically implies concerns regarding unapproved new animal drugs, misbranding, or non-compliance with Good Manufacturing Practices (GMP) within the animal health sector.
Firms should conduct a comprehensive internal audit of label claims and marketing materials to ensure no therapeutic or medical claims are made for unapproved animal products. Regulatory teams must verify that all marketed veterinary products have the appropriate FDA marketing authorization or meet exemption criteria.
FDA Warning Letter issued to: AHC Products, Inc.. 06/12/2026 — Center for Veterinary Medicine. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ahc-products-inc-728604-06122026
Open in openFDA / FDA.gov